🇺🇸 Vaxzevria in United States
579 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 579
Most-reported reactions
- Fatigue — 103 reports (17.79%)
- Headache — 69 reports (11.92%)
- Arthralgia — 59 reports (10.19%)
- Pain In Extremity — 55 reports (9.5%)
- Dyspnoea — 53 reports (9.15%)
- Pain — 52 reports (8.98%)
- Nausea — 50 reports (8.64%)
- Pyrexia — 48 reports (8.29%)
- Off Label Use — 45 reports (7.77%)
- Vomiting — 45 reports (7.77%)
Other Other approved in United States
Frequently asked questions
Is Vaxzevria approved in United States?
Vaxzevria does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Vaxzevria in United States?
Medical University Innsbruck is the originator. The local marketing authorisation holder may differ — check the official source linked above.